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Constitutive CD27/CD70 Interaction Induces
Expansion of Effector-Type T Cells
and Results in IFN-Mediated B Cell Depletion
including the CD28 relative ICOS and members of the
TNF receptor (TNFR) family, e.g., CD27, OX-40, and 4-1BB
(Watts and DeBenedette, 1999). Whether or not distinct
costimulatory receptors alter the outcome of T cell acti-
vation in qualitative terms is still poorly explored.
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TNFR family members are type 1 membrane proteins1 Department of Hematology
containing cysteine-rich repeats and can be divided intoAcademic Medical Center
two groups on the basis of their cytoplasmic domains2 Department of Immunobiology, CLB
(Chan et al., 2000; Screaton and Xu, 2000). The deathSanquin Blood Supply Foundation and
domain (DD), containing family members such asLaboratory for Experimental
CD120a (TNFR1), CD95 (Fas/Apo-1), DR3, DR4, and DR5and Clinical Immunology
can activate caspase cascades leading to apoptosis.Academic Medical Center
The non-DD-containing TNFR family members include3 Laboratory for Experimental Immunology
CD120b (TNFR2), LT-R, CD27, CD30, CD40, OX40,4 Department of Pathology
4-1BB, HVEM (ATAR, TR2), RANK (OPG), and GITR,Academic Medical Center
which affect expansion, differentiation, and survival.5 Division of Cellular Biochemistry and
These TNFR family members can bind TRAF adaptor6 Division of Molecular Genetics
molecules, which are able to relay signals to the intracel-The Netherlands Cancer Institute
lular compartent. Most TNF ligand family members areAmsterdam
type II membrane molecules and likely exist as homotri-The Netherlands
mers. The TNF-like ligands exert their physiological ef-
fects by binding to TNFR family members. Still, reverse
signaling properties have been reported for CD70Summary
(CD27L), CD153 (CD30L), CD154 (CD40L), and CD134L
(OX40L) (Bowman et al., 1994; Stuber et al., 1995; vanThe interaction between the TNF receptor family mem-
Essen et al., 1995; Wiley et al., 1996; Lens et al., 1999).ber CD27 and its ligand CD70 provides a costimulatory
Murine and human CD27 is expressed on T cells,signal for T cell expansion. Normally, tightly regulated
B cells, and NK cells (van Lier et al., 1987; Klein etexpression of CD70 ensures the transient availability
al., 1998; Sugita et al., 1992; Gravestein et al., 1995).of this costimulatory signal. Mice expressing constitu-
Recently, CD27 expression has also been found on mu-tive CD70 on B cells had higher peripheral T cell num-
rine hematopoietic progenitor cells (Wiesmann et al.,bers that showed increased differentiation toward ef-
2000). The expression of CD27 on naive T cells is consti-fector-type T cells. B cell numbers in CD70 transgenic
tutive, but after activation via the TCR-CD3 complex,(TG) mice progressively decreased in primary and sec-
CD27 is strongly upregulated (de Jong et al., 1991).ondary lymphoid organs. This B cell depletion was
Subsequently, interaction between CD27 and its ligandcaused by CD27-induced production of IFN in T cells.
CD70 induces a decrease of CD27 membrane expres-We conclude that apart from its role in controlling
sion and the release of its soluble form (Hintzen et al.,the size of the activated T cell pool, CD27 ligation
1994). Loss of CD27 expression markedly coincides withcontributes to immunity by facilitating effector T cell
the acquisition of effector functions in humans (Hamanndifferentiation.
et al., 1997) as well as in mice (P.A.B. et al., unpublished
data). CD70 is an activation molecule which is transiently
Introduction
upregulated on both murine and human T and B cells
after stimulation (Hintzen et al., 1994; Lens et al., 1996,
Adaptive immune responses to pathogens require 1997; Tesselaar et al., 1997; Oshima et al., 1998) and
proper activation, expansion, differentiation, and migra- recently found to be expressed on stimulated murine
tion of antigen-specific lymphocytes. T cell activation is dendritic cells (Akiba et al., 2000). Expression of CD70
initiated by ligation of the TCR by peptide-MHC com- on stimulated T and B lymphocytes appears to be under
plexes. However, proliferation and acquisition of effector direct control of antigen since withdrawal of the antigen
functions by naive T cells only ensues when additional receptor signal results in a rapid loss of cell surface
or costimulatory signals are provided by antigen pre- expression. This regulation may provide the immune
senting cells (APC). The Ig superfamily member CD28, system with a mechanism that allows clonal expansion
a receptor for both CD80 and CD86 molecules, is consid- of T cells in an adaptive response to the presence of
ered to be the primary costimulatory receptor for induc- antigen. Although antigen receptor and costimulatory sig-
ing high-level IL-2 production and survival of T cells nals are the major inducers of CD70 on both T and B cells,
(Chambers and Allison, 1997). However, not all T cell- expression of the molecule is under strict cytokine regula-
mediated immune responses are CD28 dependent, and tion. Proinflammatory cytokines such as IL-1, IL-12,
additional costimulatory receptors have been identified and TNF strongly enhance CD70 expression, whereas
antiinflammatory cytokines like IL-4 and IL-10 decrease
CD70 expression (Lens et al., 1997).7 Correspondence: r.vanlier@amc.uva.nl
8 These authors contributed equally to this work. The cytoplasmic tail of CD27 has been found to asso-
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Figure 1. Generation of TG Mice Overexpressing CD70 in the B Cell Compartment
(A) Schematic representation of the hCD19-mCD70 DNA construct, showing the human CD19 promoter region (hatched box) and the three
exons of the mCD70 gene, containing the 5 and 3 untranslated regions (open boxes), the intracellular part (blocked box), the transmembrane
region (black box), and the extracellular part (dotted box).
(B) Southern blot analysis of tail DNA isolated from WT and CD70TG mice (founder lines 10, 12, and 13). 32P-labeled mCD70 cDNA was used
as probe for the presence of the CD70 transgene.
(C) Representative flow cytometric analysis of CD70 expression. Splenocytes of 4-week-old WT and CD70TG mice (lines 12 and 13) were
stained with FITC-conjugated anti-CD70 mAb (clone 3B9) and APC-conjugated anti-B220 mAb and subjected to flowcytometry.
ciate with TRAF2 and 5 and thereby to signal to Jun that CD27/CD70 interactions are instrumental in gener-
ating effector T cells. To create a situation in which CD70N-terminal kinase and to NF-B (Akiba et al., 1998;
Gravestein et al., 1998). In addition, Siva-1, a proapo- is present as a dominant costimulatory ligand for T cells,
TG mice were generated that constitutively expressptotic protein, has been reported to bind to the cyto-
plasmic moiety of CD27 (Prasad et al., 1997). In vitro CD70 on B cells. Studies in these CD70TG mice demon-
strate that the CD27/CD70 system is a highly potentstudies revealed that in both human and mouse, CD27/
CD70 interactions are involved in T cell costimulation activator of T cells in vivo and plays a regulatory role
not only in expansion but also in effector cell formation.for expansion and effector cell differentiation (van Lier
et al., 1987; Hintzen et al., 1995; Gravestein et al., 1995;
Tesselaar et al., 1997; Oshima et al., 1998; Goodwin et Results
al., 1993). It is of interest that whereas CD28 ligation
strongly augments IL-2 synthesis and cell cycle progres- Generation of B Cell-Specific CD70TG Mice
In normal immune responses, CD70 is only transientlysion (Fraser et al., 1991; Boonen et al., 1999), CD27
ligation does not. Rather, in vitro triggering of CD27 has expressed on activated B cells (Lens et al., 1996). To
obtain constitutive CD70 expression in B cells, a con-been suggested to enhance TNF secretion (Hintzen et
al., 1995), promote the generation of cytolytic T cells struct containing the mCD70 gene under control of the
human CD19 promoter region (Kozmik et al., 1992) was(Goodwin et al., 1993; Brown et al., 1995), and prolong
survival of CD3-stimulated T cells (Hendriks et al., 2000). used to generate TG mice (Figure 1A). The hCD19-
mCD70 construct was injected into fertilized oocytes ofWhen infected with influenza virus, CD27-deficient
mice display an impaired expansion of antigen-specific C57BL/6 mice. Genomic Southern blot analysis identi-
fied three founder mice carrying four to five copies ofT cells in both primary and secondary responses (Hen-
driks et al., 2000). These observations imply that CD27/ the transgene (Figure 1B). Two founder lines transmitted
the transgene successfully (lines 12 and 13). FACS anal-CD70 interactions coregulate the size of the expanded
T cell pool in vivo. Additionally, the fact that ligation of ysis of splenic cells of 4-week-old CD70TG mice, using
anti-B220 and anti-CD70 antibodies, confirmed B cell-CD27 not only induces loss of its membrane expression
but also the induction of effector functions may suggest specific expression (Figure 1C). TG lines 12 and 13 both
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Figure 2. Normal T Cell Development and CD27 Expression in Thymus, but Downmodulation of CD27 Expression in Peripheral Lymphoid
Organs of CD70TG Mice
(A) Normal T cell development in thymus of 4-week-old CD70TG mice. Thymocytes were stained with FITC-conjugated anti-CD4 mAb and
PE-conjugated anti-CD8 mAb.
(B) CD27 expression is downmodulated on T cells of 4-week-old CD70TG mice in spleen and peripheral lymph nodes but not in thymus. Cell
suspensions of thymus, spleen, and lymph nodes from WT and CD70TG mice were stained with FITC-conjugated anti-CD27 mAb and PE-
conjugated anti-Thy1.2 mAb.
Numbers indicate the percentages of total viable cells (based on forward scatter and side scatter properties) within defined regions. Shown
are representative results of eight independent experiments.
gave specific expression of CD70 on B cells, and copy mice had an average increase of 23% of CD4 and 31%
of CD8 T cells in the spleen and 51% of CD4 andnumbers 4 and 5, respectively, correlated with the
amount of CD70 expression. The amount of CD70 ex- 53% of CD8 T cells in the lymph nodes. The forward
scatter profile of gated CD3 cells showed that CD70TGpressed on founder line 12 was in the same order of
magnitude as that on in vitro-activated B cells (data not mice contained a higher percentage of large, blastoid
T cells in spleen and lymph nodes (Figure 3B). In sum-shown). The experiments presented below were per-
formed using both TG lines. mary, transgenically expressed CD70 functionally inter-
acts with CD27 on T cells in the secondary lymphoid
organs and induces T cell expansion and activation inExpansion and Activation of the T Cell Compartment
in CD70TG Mice the absence of deliberate antigenic challenge.
Based on the expression patterns of CD4 and CD8 (Fig-
ure 2A) and thymic cellularity (data not shown), CD70 Chronic Expression of CD70 Drives Differentiation
toward Memory/Effector-Typeoverexpression on B cells had no overt consequences
for T cell development in the thymus. Next, we examined CD27neg T cells appear to represent effector type cells
both in humans (Hamann et al., 1997) and in mice (P.A.B.the amount of membrane-expressed CD27 as a hallmark
for functional interaction between CD70 on B cells with et al., unpublished data). In vitro studies have shown
that CD70-transfected cell lines not only reduce CD27CD27 on T cells. A strong reduction of CD27 expression
on T cells was observed in spleen and lymph nodes of expression but also induce a number of effector func-
tions in T cells (Goodwin et al., 1993; Brown et al., 1995).CD70TG mice as compared to wild-type (WT), whereas
in the thymus, CD27 expression was normal (Figure 2B). We tested if CD27/CD70 interactions are involved in
memory/effector cell formation in vivo. For both CD4Thus, only in the secondary lymphoid organs where
B-T cell interactions can occur was downmodulation of and CD8 T cells of CD70TG mice, a strong increase in
the number of T cells with a memory/effector phenotype,CD27 observed.
CD70TG mice of 4 and 8 weeks of age had lymphade- i.e., CD44hiCD62Lneg (Sprent and Tough, 1994), was
found when compared to WT (Figure 4A). The activation-nopathy, most prominent in axillary, brachial, and ingui-
nal lymph nodes. Compared with WT mice, the absolute associated isoform of CD43 was shown to be a reliable
marker for effector CD8 T cells (Harrington et al., 2000).numbers of CD4 and CD8 T cells in spleen and lymph
nodes of CD70TG mice were significantly increased (Fig- Expression of this CD43 epitope was found to be en-
hanced on CD4 and CD8 T cells from CD70TG mice,ure 3A). Four-week-old CD70TG mice had an average
increase of 18% of CD4 and 28% of CD8 T cells in thereby corroborating increased effector cell differentia-
tion in these animals (Figure 4B). The increase of T cellsthe spleen and 40% of CD4 and 44% of CD8 T cells
in the lymph nodes. At the age of 8 weeks, CD70TG with a memory/effector phenotype was evident not only
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Figure 3. Increased T Cell Numbers and an
Activated T Cell Compartment in CD70TG
Mice
(A) Increased T cell numbers in spleen and
peripheral lymph nodes of 4- and 8-week-old
CD70TG mice (black bar) as compared to WT
mice (white bar). Cells from spleen and pe-
ripheral lymph nodes were counted and
stained with FITC-conjugated anti-CD4-mAb
and PE-conjugated anti-CD8-mAb. Data rep-
resent the mean values standard deviations
of six to ten individual mice. Asterisks denote
a significant difference (p  0.05) as deter-
mined by Student’s t test.
(B) Histogram profiles of splenic CD3 T cells
for forward scatter (FSC, linear scale) from
8-week-old WT and CD70TG mice. The per-
centages indicate the relative amount of blas-
toid cells within the T cell compartment.
in spleen but also in peripheral blood and lymph nodes. CD70TG Mice Show a Progressive Decline
in B Cell NumbersExpression of the early activation markers CD69 and
CD25 was not significantly different between WT and In marked contrast to increased cellularity of the T cell
compartment, B cell numbers were reduced in allCD70TG mice (data not shown).
Cytokine expression was determined by intracellular lymphoid organs of CD70TG mice. Compared to WT
mice, 4-week-old CD70TG mice had on average an 83%staining of T cells that had been stimulated with phorbol
ester and ionomycin. Comparable percentages of IL-2 reduction in absolute B cell numbers in bone marrow
and 58% in the spleen. At this age, a normal amountand TNF-producing splenic CD4 and CD8 cells were
found in CD70TG mice and their WT littermates (Figure of B cells was found in lymph nodes (Figure 5A). The
decrease in B cell numbers progressed in 8-week-old4C). However, a significant increase in IFN-producing
T cells was found in both CD4 and CD8 T cells (Figure CD70TG mice to 93% in bone marrow, 72% in spleen,
and 50% in lymph nodes (Figure 5A). In 12-week-old4C). In addition, the mean expression of IFN was on
average 1.5-fold increased in T cells of CD70TG mice mice, B cells were hardly detectable in the lymphoid
organs (98% reduction in bone marrow, 94% in spleen,(data not shown). The enhanced IFN production corre-
lated with upregulation of IFN-responsive genes such and 86% in lymph nodes). In addition, peritoneal B1
cells (IgMCD5) also were diminished in CD70TG miceas MHC-class II on splenic B cells and Sca-1 (Ly-6A/E)
on bone marrow-derived cells (Figure 4D). Finally, levels (data not shown). The serum immunoglobulin levels in
4- and 8-week-old CD70TG mice were reduced, espe-of IL-4 were below detection thresholds in both WT and
CD70TG animals (data not shown). These data indicate cially IgG2a, IgG2b, and IgG3 (Figure 5B).
Immunohistochemical analyses of spleen sections ofthat CD70 potently stimulates the development of CD4
and CD8 memory/effector T cells. 4- and 8-week-old CD70TG mice with anti-CD3 and anti-
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B220 antibodies showed a characteristic segregation in that constitutive CD27 ligation on stem cells is responsi-
ble for the alterations within the B cell compartment.the white pulp of T and B cell areas (Figure 5C), but
enlarged T cell areas and diminished B cell follicles were To directly assess the role of T cells in the B cell
depletion, syngenic WT T cells were adoptively trans-observed. Interestingly, in most cases B cell areas of
CD70TG mice contained more T cells than those of WT ferred into CD27	/	 
 CD70TG mice. The recipients had
a comparable B cell reduction to the CD70TG mice (Fig-mice (note the section of 8-week-old CD70TG mice,
Figure 5C). ure 6A). A modest reduction of B cell numbers occurs
upon adoptive transfer of effector cells into WT miceThe progressive decrease in B cell numbers could
either be due to a block in B cell development by an (data not shown), indicating that the activation and dif-
ferentiation toward effector T cells is dependent on theintrinsic property of the CD70TG B cells or by an elimina-
tion mechanism that is not cell autonomous. The in vitro repeated interaction between CD27 and CD70. Thus,
the reduced B cell numbers in the CD70TG mice are aresponses of purified CD70TG B cells to lipopolysaccha-
ride (LPS), anti-CD40 mAb, and anti-IgM mAb were com- consequence of the interaction between CD70-express-
ing B cells and CD27-expressing T cells.parable to those of WT B cells, indicating no intrinsic
deficiency of the CD70TG B cells to respond to general
stimuli (data not shown). In addition, normal antibody T Cell-Mediated B Cell Depletion in CD70TG Mice
responses were found after primary immunization with Is Caused by IFN
a T cell-dependent antigen (TNP-KLH), but lower T cell- Both CD4 and CD8 T lymphocytes can eliminate other
independent antibody responses (TNP-Ficoll) were cells by three effector mechanisms: the perforin/gran-
found (K.T. et al., unpublished data). zyme system, the CD95/CD95L system, and secretion
Analysis of the B cell compartment in bone marrow of cytokines such as IFN and TNF (Shresta et al., 1998).
of 4-week-old CD70TG mice and of WT mice revealed To investigate which of these effector mechanisms was
that the immature/mature fraction (B220IgM) of B involved in the T cell-mediated B cell depletion in the
cells was relatively more reduced than the pro/pre-B CD70TG mice, adoptive transfers of T cells derived from
cells (B220IgM	; Figure 5D). In contrast, peripheral mice deficient in cytotoxic effector mechanisms were
B cell subsets categorized into fractions I, II, and III, performed. Figure 6B shows that T cells derived from mice
based on the relative levels of IgM versus IgD (Hardy et deficient in perforin, CD95L, or TNF were as capable as
al., 1982), displayed modest differences in their relative WT T cells of reducing B cell numbers in CD27	/	 

profiles (Figure 5D). Together, these results indicate that CD70TG mice. In marked contrast, T cells from IFN	/	
CD27/CD70 interactions negatively regulate B cell de- mice did not affect B cell numbers.
velopment in the bone marrow. To substantiate that IFN secretion is the effector
mechanism mediating B cell depletion, CD70TG mice
were crossed with IFN	/	 mice. Like CD70TG mice,B Cell Depletion in CD70TG Mice Is Dependent
IFN	/	 
 CD70TG mice have an activated T cell com-on CD27 and Mediated by T Cells
partment as shown by enlarged lymph nodes and accu-To determine whether interaction of the CD70 molecule
mulation of CD44hiCD62Lneg T cells (data not shown).with CD27 is required for the B cell depletion, CD70TG
Still, B cell numbers were normal when compared withmice were crossed with mice deficient for the CD27
IFN	/	 mice (Table 1). Importantly, this observation notgene. CD27	/	 mice have an undisturbed development
only formally rules out the possibility that the B cellof the lymphoid compartment and normal T and B cell
depletion is caused by CD70 ligation on TG B cells bynumbers (Hendriks et al., 2000). Since CD27	/	 

CD27, but establishes that constitutive triggering ofCD70TG mice have normal B cell numbers in both the
CD27 on T cells in vivo results in IFN-mediated B cellprimary and secondary organs (Table 1; Figure 6), it can
depletion.be concluded that CD27 is essential for the reduced
B cell numbers in CD70TG mice and corroborates the
notion that CD70TG B cells have no intrinsic impairment. Discussion
Expression of CD27 in mice is found on T cells, B cells,
NK cells, and progenitor cells. Any of these cell types CD27/CD70 Interactions Regulate T Cell Expansion
Numerous in vitro studies have established that CD27could be responsible for disturbed B cell development
in CD70TG mice. Since only antigen-experienced B cells transmits costimulatory signals for T cell expansion.
However, in these assays, the effects of CD27 ligationexpress CD27, a direct effect of CD27 triggering on B cells
is unlikely to be responsible for the decrease in B cell are relatively moderate when compared to the conse-
quences of CD28 triggering. Remarkably, the studies innumbers. NK cell depletion with anti-NK1.1 antibodies did
not alter the reduction in B cell numbers in CD70TG mice the B cell-specific CD70TG mice here show that the
CD27/CD70 system is a very potent stimulator of T cellas compared to control antibody-treated CD70TG mice
(data not shown). To test T cell involvement, CD70TG expansion in vivo. In agreement with this presumed role,
CD27	/	 mice show a diminished expansion of antigen-mice were crossed with mice lacking T cells due to
genomic deletion of the TCR locus. The number of specific T cells after influenza virus infection (Hendriks et
al., 2000). The signal transduced via CD27 is qualitativelyB cells in the bone marrow, spleen, and lymph nodes of
TCR	/	 
 CD70TG mice was normal (Table 1), which different from the CD28-derived signal, since CD27 liga-
tion does not augment the production of IL-2 nor doesstrongly implies that B cells are eliminated during devel-
opment in a T cell-dependent fashion. Furthermore, since it enhance cell cycle entry or activity in vitro (Hintzen et
al., 1995; Hendriks et al., 2000). Indeed, although T cellCD27 expression on progenitor cells in TCR	/	 

CD70TG mice is normal (data not shown), it is unlikely activation is evident in CD70TG mice, the percentage of
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Figure 4. Increased Differentiation toward Memory/Effector-Type T Cells in CD70TG Mice
(A) Increased percentages of CD44hiCD62Lneg cells in spleens of CD70TG mice compared to WT mice. Single-cell suspensions of spleens,
isolated from 8-week-old WT and CD70TG mice, were stained with FITC-conjugated anti-CD62L mAb and PE-conjugated anti-CD44 mAb.
Numbers represent the percentages of positive cells in indicated regions within the CD3 gate. Separate analyses of CD4 and CD8 T cells
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IL-2-producing T cells is comparable to that of WT mice. the CD27 signal can be bypassed by other receptors
since CD27-deficient mice have a normal capacity toThese studies appear to be in agreement with earlier ob-
servations that CD27 signaling does not exert its major generate IFN-producing T cells (Hendriks et al., 2000).
effect via the induction of IL-2 (Goodwin et al., 1993).
The TNFR family members OX40 and 4-1BB share a Effects of CD70 Outside the T Cell Compartment
number of signaling components with CD27, notably Depend on Enhanced Secretion of IFN
TRAF2 and 5. As these receptors and their respective In CD70TG mice, a strong reduction of B cell numbers
ligands can be expressed during the same stages of in lymphoid organs and bone marrow is found. This B cell
immune responses, they may work either in series and/ depletion is not due to an intrinsic defect of CD70TG
or in parallel with CD27 to determine the size of ex- B cells, because their capacity to proliferate to a variety
panded T cell pool. Recently, it has been shown that of stimuli is similar to that of WT B cells, and they mount
mice that cannot utilize either OX40 or 4-1BB receptor adequate antibody responses to T cell-dependent anti-
systems have, like CD27	/	 mice, problems in mounting gens. Rather, depression of the B cell system is due
adequate immune responses to protein and viral anti- to the effect of IFN-secreting T cells that inhibit the
gens (DeBenedette et al., 1999; Tan et al., 1999; Kopf outgrowth of B cells in the bone marrow (Figures 5D
et al., 1999; Chen et al., 1999). Still, all these mutant and 6B). A direct effect of IFN would be in accordance
mice retain a certain capacity to respond to antigenic with several in vitro experiments showing inhibitory ef-
challenge, suggesting that costimulatory receptors may fects of IFN on proliferation of B cell precursors (Gra-
compensate for the loss of others. wunder et al., 1993; Gimble et al., 1993; Garvy and Riley,
1994). Furthermore, IFNTG mice have a similar reduc-
tion of B cells in bone marrow, spleen, and lymph nodesCD27/CD70 Involvement in the Generation
of Effector T cells (Young et al., 1997). Finally, SOCS-1-deficient mice that
are hyperresponsive to IFN have a complex phenotypeIn the B cell-specific CD70TG mice, we observed a striking
accumulation of CD27negCD43hiCD44hiCD62Lneg memory/ including severe B cell depletion. As for CD70 TG mice,
these clinical features are eliminated on an IFN	/	effector-type T cells that produce increased amounts of
IFN but not IL-2. Studies in the human system have background (Alexander et al., 1999).
CD70TG mice have a similar B cell phenotype as CD80provided indirect evidence for the involvement of CD27/
CD70 interactions in the generation of effector-type (B7.1) or CD86 (B7.2) TG mice. Both types of mice have
decreased B cell numbers in bone marrow (Sethna etcells. CD70 induces downmodulation of CD27 and re-
lease of its soluble form (Hintzen et al., 1994). Concomi- al., 1994; Fournier et al., 1997; Van Parijs et al., 1997).
CD86-expressing B cells are specifically eliminated dur-tantly, CD27 triggering causes acquisition of CD8 T cell
effector function (Goodwin et al., 1993; Brown et al., ing their maturation due to interactions with T cells by
an unknown mechanism (Fournier et al., 1997). A similar1995). Other studies have indicated that CD27 negativity
can be regarded as a stable trait of both CD4 and CD8 mechanism might underlie the B cell depletion in CD80TG
and CD86TG mice as reported here for B cell depletioneffector T cells (Hamann et al., 1997). In support of their
effector-type status, CD27neg peripheral T cells also lack in CD70TG mice. CD70 and CD80/CD86 are unlikely to
play successive roles in the same costimulatory path-CCR7 expression, which renders them unable to recircu-
late to lymph nodes but rather implies that they migrate way because CD70TG B cells do not have increased
levels of CD80/CD86 molecules (R.A., unpublished data).to solid tissues (Gamadia et al., 2001). The data obtained
in the human system together with the findings of the Expansion of the T cell compartment appears to be more
prominent in CD70TG than in either CD80TG or CD86TGCD70TG mice suggest that CD27/CD70 interactions are
important in effector cell differentiation. In this scenario, mice. This may partially be a technical issue related to
the differences in the promoters used for expression ofthe amount of CD70 that is induced during infections is
an important parameter for the number of effector T cells the transgene. Alternatively, CD28 signaling is physio-
logically counteracted by CTLA-4 signaling, but a com-that are generated. It is unclear at this moment whether
CD27 signaling itself is sufficient to drive differentiation petitor of CD27 signaling has not been identified. In the
absence of a natural antagonist, T cells may be unable totoward IFN-secreting effector T cells or whether CD27/
CD70 interactions only sensitize for differentiation- escape from the CD70 signal. Collectively, data obtained
with CD80TG, CD86TG, and CD70TG mice show thatinducing signals such as IL-12. Furthermore, as has
been discussed for the regulation of expansion of anti- deregulated delivery of costimulatory signals may have
a severe impact on cells outside the T cell lineage. It isgen-primed T cells, it is likely that to a certain extent,
gave similar results (not shown). Shown are representative results out of eight independent experiments.
(B) Increased expression of the high molecular weight isoform of CD43 on CD4 and CD8 T cells of CD70TG mice. Splenocytes were isolated
from 8-week-old WT and CD70TG mice and stained with PE-conjugated CD43 (1B11) mAb and PerCP-conjugated anti-CD4 mAb or anti-CD8
mAb. Numbers represent the percentages of CD43hi cells within the CD4 or CD8 gate.
(C) Increased percentages of IFN-producing T cells in CD70TG mice. Spleen cells of 8-week-old WT and CD70TG mice were stimulated for
4 hr with PMA ionomycin in the presence of the protein-secretion inhibitor Brefeldin A and subsequently intracellularly stained for IL-2, TNF,
and IFN. The percentage of positive cells within the CD4 and CD8 gated cells are indicated. Each dot represents the cytokine production
of the cells of one individual mouse (n  8). Asterisks denote significant differences (p  0.05) as determined by Student’s t test.
(D) Higher expression of IFN-responsive genes in CD70TG mice. Single-cell suspensions of bone marrow and spleen from 8-week-old WT
and CD70TG mice were stained with anti-Sca-1 (Ly6A/E) mAb and anti-MHC-class II mAb. Data presented are gated on total cell population
for Sca-1 and gated on B220 cells for MHC-class II.
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Figure 5. Progressive Reduction of B Cell Numbers and Reduced Immunoglobulin Levels in CD70TG Mice
(A) Progressive reduction of B cell numbers in bone marrow, spleen, and lymph nodes in 4- and 8-week-old CD70TG mice. Cells from bone
marrow, spleen, and peripheral lymph nodes of 4- and 8-week-old WT (white) and CD70TG (black) mice were counted and stained with anti-
B220-APC and analyzed by flow cytometry. Data represent the mean values  standard deviations of eight to ten different mice. Asterisks
denote significant differences (p  0.05) as determined by Student’s t test.
(B) Serum immunoglobulin levels of 4- and 8-week-old WT (open circles) and CD70TG mice (filled circles). Concentrations of different
immunoglobulin isotypes were determined by isotype-specific ELISA. Each circle represents an individual mouse. Asterisks denote significant
differences (p  0.05) as determined by Student’s t test.
(C) Immunohistochemical staining of B and T cells in the spleen of 4- and 8-week-old WT and CD70TG mice. Cryostat sections were double
stained for B220 B cells (blue stain) and CD3 T cells (red stain).
(D) Reduction in numbers of immature and mature B cells in CD70TG mice. Representative flow cytometric analysis of single-cell suspensions
of 4-week-old WT and CD70TG mice from bone marrow and spleen. Cells were stained with mAbs specific for IgM, IgD, and B220. Numbers
indicate the percentages of the total gated viable cell populations that fall into the indicated squares.
important to note that in none of the described geneti- needed to induce the effects on the B cell lineage. This
suggests that either environmental antigens, presentcally modified mice (SOCS-1	/	, IFNTG, CD70TG,
CD80TG, and CD86TG) is deliberate antigenic challenge under specific pathogen-free conditions, can induce lev-
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Table 1. Total B Cell Numbers of CD70TG Mice on CD27	/	, TCR	/	, and IFN	/	 Backgrounds
Bone Marrow Spleen Lymph Nodes
Mice B220IgM	 (
 106) B220IgM (
 106) B220 (
 106) B220 (
 106)
WT 3.4  1.0 1.8  0.9 56.7  7.8 5.7  1.6
CD70TG 0.5  0.1a 0.1  0.05a 14.0  9.6a 2.7  1.7a
CD27	/	 3.7  1.5 1.9  0.6 44.1  9.0 4.3  2.1
CD27	/	 
 CD70TG 4.1  1.0 2.6  1.0 41.3  10.7 3.7  2.5
TCR	/	 2.4  0.9 1.1  0.4 45.1  7.1 ND
TCR	/	 
 CD70TG 2.5  0.6 0.9  0.2 40.8  3.5 ND
IFN	/	 4.2  0.6 1.6  0.7 39.6  4.6 3.0  0.4
IFN	/	 
 CD70TG 3.5  0.9 1.3  0.4 39.7  6.2 2.7  0.3
Values ( standard deviation) represent results obtained from four to eight different 8-week-old mice. B cell numbers were calculated based
on the percentage of lymphocytes expressing the indicated cell surface markers as determined by two-color immunofluorescence analysis
with anti-IgM mAb and anti-B220 mAb of cell suspensions of bone marrow, spleen, and lymph nodes.
a The percentage of cells was significantly less than in control littermates (p  0.05; Student’s t test).
the animal facility of the NKI. CD95L	/	 (FasLgld) and TNF	/	 miceels of T cell activation sufficient for these effects or that
(Pasparakis et al., 1996) were kindly provided by Dr. J.P. Medemachronic coreceptor ligation in vivo is not a neutral event
(Leiden University Medical Center, Leiden), perforin-deficient micebut has a stimulatory effect for the T cell compartment
(Kagi et al., 1994) were kindly provided by Dr. Ossendorp (Leiden
even in the absence of TCR ligation. University Medical Center, Leiden), and IFN	/	 (C57BL/6-Ifngtm1Ts)
mice (Dalton et al., 1993) were purchased from Jackson Laboratories
(Bar Harbor, ME). All mice strains were on a C57BL/6 backgroundPathophysiology of Deregulated CD70 Expression
except for TCR	/	 mice, which were on a mixed background ofIn agreement with its strict regulation by antigen and
C57BL/6 and 129/Ola. Identification of mutant mice was performedcytokines, CD70 is only sparsely detected in normal
as described by PCR analysis of tail DNA or by FACS analysis ofhuman lymphoid tissue (Lens et al., 1999). Still, abundant
peripheral blood cells.
CD70 expression has been documented in Hodgkin’s
and Reed-Sternberg cells on lymphocytes from chronic
Southern Blot AnalysisB cell lymphocytic leukemia patients (Gruss and Dower,
Genomic DNA was obtained from tail biopsies and digested with
1995). Markedly, also in chronic viral infections, proto- HindIII, separated on a 0.8% agarose gel, transferred to Hybond
typically HIV infection, enhanced expression of CD70, membrane, and hybridized with 32P-labeled mCD70 cDNA probe,
and aberrant CD27 expression have been reported followed by washes and autoradiography. The probe was prepared
by PCR with the primers 5-GGATGCCGGAGGAAGGTCGCCC-3(Wolthers et al., 1996). Finally, several studies in mouse
and 5-CAAGGGCATATCCACTGAACTC-3, and with mCD70 cDNAtumor models have demonstrated that CD70 is a potent
as template.adjuvant to induce antitumor T cell immunity (Nieland
et al., 1998; Couderc et al., 1998; Lorenz et al., 1999).
Flow CytometryBased on the findings reported here, this may be related
Single-cell suspensions were obtained from spleen, lymph nodesto the fact that CD27/CD70 could be instrumental in the
(axillary, brachial, inguinal, and mesenteric), and thymus by grindingexpansion of effector-type T cells. If indeed no counter-
the tissues through nylon sieves, as well as from bone marrow
acting mechanisms for the CD27 signal are operational, (femurs and tibias) by flushing the bones with a needle. Erythrocytes
this would make CD70 an attractive candidate adjuvant in spleen, bone marrow, and blood preparations were lysed with
to promote effector T cell differentiation, alone or in ammonium chloride solution. Cells (4 
 105 ) were collected in 96-
well U-bottomed plates in FACS staining buffer (PBS, 0.5% bovinecombination with other costimulatory ligands, to include
serum albumin, 20 mM NaN3). All samples were preincubated forin antitumor vaccines.
10 min with anti-CD16/CD32 (FcBlock, clone 2.4G2, Pharmingen)
and subsequently stained for 30 min at 4C with antibodies. Finally,Experimental Procedures
analysis was performed on a FACSCalibur using Cell Quest software
(Becton Dickinson). Viable populations were gated on the basisGeneration of CD70TG Mice
of forward scatter and side scatter, and 20,000 cells/sample wereDNA encoding the mCD70 gene was isolated from a P1 plasmid
analyzed.(Tesselaar et al., 1997) and cloned into the HindIII site of pBluescript
The following antibodies were obtained from Pharmingen (San(KS/	). Subsequently, a 6 kb DNA fragment containing the human
Diego, CA): CD3-allophycocyanin (APC) (clone145-2C11), CD4-flu-CD19 promoter (kindly provided by M. Busslinger, Research Institute
orescein isothiocyanate (FITC) or peridinin chlorophyll proteinof Molecular Pathology, University of Vienna, Austria) was cloned
(PerCP) (clone RM4-5), CD5-phycoerythrin (PE) (clone 53-7.3),into the NotI site of this plasmid, resulting in a 14 kb construct. The
CD8a-PE or PerCP (clone 53-6.7), CD25 (clone 7D4), CD40-FITCconstruct was digested with XhoI and SstII to release the 11 kb
(clone HM40-3), CD43-PE (clone S7, clone 1B11), CD44-PE (cloneDNA fragment (Figure 1A). DNA was microinjected into pronuclei
IM7), CD45R/B220-FITC, biotin or APC (clone RA3-6B2), CD62L-of C57BL/6 fertilized oocytes and implanted into pseudopregnant
FITC (clone MEL-14), CD69-FITC (clone H1.2F3), CD80-PE (B7-1,female C57BL/6 mice. TG founders were identified by Southern blot
clone 16-10A1), CD86-PE (B7-2, clone GL1), Ly-6A/E-Biotin (Sca-1,analysis of tail DNA and propagated by mating with WT C57BL/6
clone D7), NK-1.1 (clone PK136), and Thy1.2-PE (clone 51-8). Anti-mice. Offspring were tested for presence of the transgene by flow
bodies obtained from Southern Biotechnology Association (Bir-cytometric analysis of peripheral blood cells with anti-mCD70-FITC
mingham, AL) were: IgM-FITC (clone 1B4B1) and IgD-PE (clone 11-(clone 3B9). Mice were maintained under specific pathogen-free
26). The following antibodies were purified from hybridoma superna-conditions in the animal facility of the NKI.
tants and conjugated to FITC or biotin according to standard proce-
dures: CD3 (clone 145-2C11), CD4 (clone MT4), CD8 (clone 2.43),Mice
CD27 (clone LG.3A10), CD70 (clone 3B9 and 6D8; K.T. et al., unpub-Mice strains used: C57BL/6, CD27	/	 mice (Hendriks et al., 2000),
and TCR mice (Mombaerts et al., 1992) were bred and kept in lished data), MHC-class II (clone M5/114), and NK1.1 (clone PK136).
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Figure 6. B Cell Depletion Depends on Interaction with CD27 on T Cells and Is Mediated by IFN but Not by CD95L, Perforin, or TNF
(A) Flow cytometric analysis of single-cell suspensions of spleens isolated from CD27	/	, CD70TG, and CD27	/	 
 CD70TG mice with or
without adoptively transferred WT T cells. B cells were stained with FITC-conjugated anti-IgM mAb and APC-conjugated anti-B220 mAb.
(B) B cell numbers of CD27	/	 and CD27	/	 
 CD70TG mice which were untreated or injected intravenously with T cells from WT, CD95L	/	,
perforin	/	, TNF	/	, or IFN	/	 mice. Data represent the mean values  standard deviations of three to six different recipients. Asteriks denote
a significant difference (p  0.05) as determined by Student’s t test.
For adoptive transfer, lymph nodes were isolated from either wild-type, CD95L	/	, perforin	/	, TNF	/	, or IFN	/	 mice, and T cells were
purified as described under Experimental Procedures. Syngenic recipients (CD27	/	 or CD27	/	 
 CD70TG mice) were intravenously injected
with 20 
 106 T cells. Purity of CD3 cells was 95%. After 21 days, single-cell suspensions from bone marrow and spleen were analyzed.
For detection of biotinylated antibody, streptavidin-PE (Caltag Labo- were double stained for B220 and CD3. The primary antibodies used
were biotinylated anti-B220 mAb and FITC-conjugated anti-CD3 mAbratories, CA) or streptavidin-APC (Pharmingen) was used.
(Pharmingen). For the detection of the biotinylated antibody, alkaline
phosphatase-labeled streptavidin (DAKO) was used, whereas theIntracellular Staining for Cytokines
Single-cell suspensions of spleen and lymph nodes were stimulated FITC-conjugated antibody was detected with a horseradish-peroxi-
dase labeled rabbit-anti-FITC antibody (DAKO). 3.3-amino-9-ethyl-for 4 hr with 1 ng/ml PMA and 1 M ionomycin in the presence of
the protein-secretion inhibitor Brefeldin A (1 g/ml, all from Sigma carbozole (AEC) and 5-bromo-4-chloroindothyl phosphate (Sigma)
were used as subtrate for development.Chemical Co., St. Louis, MO). After cell-surface staining with FITC-
conjugated anti-CD4-mAb and PE-conjugated anti-CD8 mAb in
FACS staining buffer, cells were washed followed by fixation (5 min, Analysis of Immunoglobulin Levels
Levels of immunoglobulin subclasses in sera were measured by4% PFA in PBS) and permeabilization (30 min, 0.1% saponin in
FACS staining buffer). Next, cells were incubated for 30 min in FACS sandwich ELISA, using unlabeled and biotinylated anti-mouse im-
munoglobulin isotype-specific antibodies (Southern Biotechnologystaining buffer supplemented with 0.1% saponin, 5% normal mouse
serum, and 2.5 g/ml CD16/CD32 Fc Block. Cells were then incu- Associates). Diluted plasma was incubated at room temperature
for 3 hr; peroxidase and tetramethylbenzidine (MERCK, Darmstadt,bated for 30 min with APC-conjugated anti-IL2 (clone JES6-5H4),
or APC-conjugated anti-TNF mAb (clone MP6-XT22) or biotinylated Germany) were used as substrate. Antibody concentrations were
calculated by using purified immunoglobulin isotypes as standards.anti-IFN mAb (clone XMG1.2) (all from Pharmingen) in FACS stain-
ing buffer with 0.1% saponin. Incubation with streptavidin-APC
(Pharmingen) was used to complete IFN staining. Adoptive Transfer into CD27	/	 and CD27	/	 
 CD70TG Mice
Lymph nodes (superficial cervical, axillary, brachial, inguinal, and
mesenteric) were isolated from 6-week-old WT, CD95L	/	,Immunohistochemistry
Spleen and lymph nodes from 4- and 8-week-old WT and CD70TG perforin	/	, TNF	/	, and IFN	/	 mice. Cells were incubated with
rat-anti-MHC-class II and rat-anti-B220 antibodies, washed once,mice were isolated and snap-frozen in liquid nitrogen; cryostat sections
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and then incubated with goat-anti-rat IgG microbeads (Miltenyi Bio- Stewart, T.A. (1993). Multiple defects of immune cell function in mice
with disrupted interferon- genes. Science 259, 1739–1742.tec, Bergisch Gladbach, Germany). After washing, cells were mag-
netically separated, and effluent fractions were consistently found to de Jong, R., Loenen, W.A., Brouwer, M., van Emmerik, L., de Vries,
be95% CD3 as evidenced by flow cytometry. Syngenic recipients E.F., Borst, J., and van Lier, R.A. (1991). Regulation of expression
(CD27	/	 or CD27	/	 
 CD70TG mice) were injected with T cells. of CD27, a T cell-specific member of a novel family of membrane
After washing with PBS, T cells (20
 106 per recipient) were injected receptors. J. Immunol. 146, 2488–2494.
intravenously into the tails of 6-week-old sex-matched CD27	/	 and
DeBenedette, M.A., Wen, T., Bachmann, M.F., Ohashi, P.S., Barber,
CD27	/	 
 CD70TG syngenic mice. After 21 days, the recipients
B.H., Stocking, K.L., Peschon, J.J., and Watts, T.H. (1999). Analysis
were sacrificed, and single-cell suspensions were made from bone
of 4–1BB ligand (4–1BBL)-deficient mice and of mice lacking both
marrow (femurs and tibia), spleen, and lymph nodes (axillary, bra-
4–1BBL and CD28 reveals a role for 4–1BBL in skin allograft rejection
chial, inguinal). Cells were counted and analyzed by flow cytometry
and in the cytotoxic T cell response to influenza virus. J. Immunol.
to determine B220 cells.
163, 4833–4841.
Fournier, S., Rathmell, J.C., Goodnow, C.C., and Allison, J.P. (1997).Statistical Analysis
T cell-mediated elimination of B7.2 transgenic B cells. Immunity 6,All data are shown as mean values standard deviations. Student’s
327–339.t test was used to determine the level of significance of differences
Fraser, J.D., Irving, B.A., Crabtree, G.R., and Weiss, A. (1991). Regu-in population means.
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